• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减体重后活体供肝移植肝内脂肪变性和纤维化指标的变化

Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction.

作者信息

Choi Jaehyuk, Choi YoungRok, Hong Su Young, Suh Sanggyun, Hong Kwangpyo, Han Eui Soo, Lee Jeong-Moo, Hong Suk Kyun, Yi Nam-Joon, Lee Kwang-Woong, Suh Kyung-Suk

机构信息

Department of Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.

出版信息

Front Surg. 2022 May 3;9:827526. doi: 10.3389/fsurg.2022.827526. eCollection 2022.

DOI:10.3389/fsurg.2022.827526
PMID:35592121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9110767/
Abstract

BACKGROUND

A short-term weight reduction program for potential living donors was introduced to reduce the extent of hepatic steatosis prior to liver transplantation. We aimed to investigate changes in non-invasive hepatic steatosis and fibrosis indices among those who completed the program.

METHODS

Among 1,950 potential living liver donors between January 2011 and May 2019, 160 living donors joined the weight reduction program. The prospectively collected clinical data of these potential liver donors were analyzed retrospectively. Hepatic steatosis and fibrosis scores were determined using the fatty liver index (FLI), hepatic steatosis index (HSI), and NAFLD fibrosis score (NFS) and compared to MR spectroscopy (MRS) fat fraction results before and after weight reduction.

RESULTS

Thirty-nine potential living donors who had undergone MRS both before and after weight reduction were included in the analysis. Their body weight decreased from 78.02 ± 10.89 kg to 72.36 ± 10.38 kg over a mean of 71.74 ± 58.11 days. FLI, HSI, and MRS values decreased significantly from 41.52 ± 19.05 to 24.53 ± 15.93, 39.64 ± 3.74 to 35.06 ± 3.82, and 12.20 ± 4.05 to 6.24 ± 3.36, respectively. No significant decreases in NFS were observed. There was a significant correlation between the extent of HSI change and the extent of MRS change (R value = 0.69, < 0.001), although there was no correlation between MRS and FLI.

CONCLUSION

The weight reduction program significantly improved non-invasive indices of hepatic steatosis over a short period. HSI may allow for prediction of simple decreases in hepatic steatosis.

摘要

背景

为潜在的活体供体引入了一项短期减重计划,以减少肝移植前肝脂肪变性的程度。我们旨在研究完成该计划者的非侵入性肝脂肪变性和纤维化指标的变化。

方法

在2011年1月至2019年5月期间的1950名潜在活体肝供体中,160名活体供体参加了减重计划。对这些潜在肝供体前瞻性收集的临床数据进行回顾性分析。使用脂肪肝指数(FLI)、肝脂肪变性指数(HSI)和非酒精性脂肪性肝病纤维化评分(NFS)确定肝脂肪变性和纤维化评分,并与减重前后的磁共振波谱(MRS)脂肪分数结果进行比较。

结果

分析纳入了39名在减重前后均接受MRS检查的潜在活体供体。他们的体重在平均71.74±58.11天内从78.02±10.89千克降至72.36±10.38千克。FLI、HSI和MRS值分别从41.52±19.05显著降至24.53±15.93、从39.64±3.74降至35.06±3.82、从12.20±4.05降至6.24±3.36。未观察到NFS有显著下降。HSI变化程度与MRS变化程度之间存在显著相关性(R值 = 0.69,P < 0.001),尽管MRS与FLI之间无相关性。

结论

减重计划在短期内显著改善了肝脂肪变性的非侵入性指标。HSI可能有助于预测肝脂肪变性的单纯降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/d9ea4b152e3b/fsurg-09-827526-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/93bd6da4a2a3/fsurg-09-827526-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/64b872c0cc92/fsurg-09-827526-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/1af8843d2144/fsurg-09-827526-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/afad548dcbae/fsurg-09-827526-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/d9ea4b152e3b/fsurg-09-827526-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/93bd6da4a2a3/fsurg-09-827526-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/64b872c0cc92/fsurg-09-827526-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/1af8843d2144/fsurg-09-827526-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/afad548dcbae/fsurg-09-827526-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71af/9110767/d9ea4b152e3b/fsurg-09-827526-g0005.jpg

相似文献

1
Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction.减体重后活体供肝移植肝内脂肪变性和纤维化指标的变化
Front Surg. 2022 May 3;9:827526. doi: 10.3389/fsurg.2022.827526. eCollection 2022.
2
Weight loss interventions in living donor liver transplantation as a tool in expanding the donor pool: A systematic review and meta-analysis.减肥干预措施在活体肝移植供者中的应用:系统评价和荟萃分析。
World J Gastroenterol. 2021 Jun 28;27(24):3682-3692. doi: 10.3748/wjg.v27.i24.3682.
3
Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.肝脂肪变性与纤维化指标、饮食习惯、身体活动及生活质量之间的关联
Arab J Gastroenterol. 2022 Nov;23(4):277-287. doi: 10.1016/j.ajg.2022.05.006. Epub 2022 Aug 1.
4
The practical utility of non-invasive indices in metabolic hepatic steatosis.无创指标在代谢性肝脂肪变性中的实际应用。
Endocrinol Diabetes Nutr (Engl Ed). 2022 Jun-Jul;69(6):418-425. doi: 10.1016/j.endien.2022.06.009. Epub 2022 Jul 2.
5
External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.使用 1H 磁共振波谱对外脂肝指数和脂滴产品指数进行验证,以在健康对照者和肥胖、胰岛素抵抗个体中识别肝脂肪变性。
Eur J Endocrinol. 2014 Nov;171(5):561-9. doi: 10.1530/EJE-14-0112.
6
Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?通过磁共振成像质子密度脂肪分数测定的可忽略不计的肝脂肪变性是否可以免除潜在肝供体的肝活检?
Liver Transpl. 2018 Apr;24(4):470-477. doi: 10.1002/lt.24965. Epub 2018 Mar 6.
7
Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.肝脂肪变指数和脂肪肝指数与 2 型糖尿病患者颈动脉粥样硬化的关系。
Int J Med Sci. 2021 Jul 23;18(14):3280-3289. doi: 10.7150/ijms.62010. eCollection 2021.
8
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation.供体减重在活体肝移植中对肝脂肪变性的影响。
Liver Transpl. 2004 Jun;10(6):721-5. doi: 10.1002/lt.20172.
9
Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.脂肪肝指数和肝脂肪变性指数预测 1 型糖尿病患者的非酒精性脂肪肝。
J Gastroenterol Hepatol. 2018 Jan;33(1):270-276. doi: 10.1111/jgh.13814.
10
Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.验证脂肪肝指数和肝脂肪变性指数在阻塞性睡眠呼吸暂停低通气综合征成人非酒精性脂肪肝疾病筛查中的应用。
Chin Med J (Engl). 2019 Nov 20;132(22):2670-2676. doi: 10.1097/CM9.0000000000000503.

引用本文的文献

1
The impact of donor liver fibrosis on the outcomes of patients who undergo liver transplant: a cohort study from UNOS database.供体肝纤维化对肝移植患者预后的影响:一项来自器官共享联合网络(UNOS)数据库的队列研究
Front Med (Lausanne). 2025 Apr 10;12:1547200. doi: 10.3389/fmed.2025.1547200. eCollection 2025.
2
Multivariable linear model for predicting graft weight based on 3-dimensional volumetry in regards to body weight change of living liver donor: an observational cohort study.基于三维容积测量法预测活体肝供体体重变化时移植肝重量的多变量线性模型:一项观察性队列研究。
Ann Surg Treat Res. 2024 Aug;107(2):91-99. doi: 10.4174/astr.2024.107.2.91. Epub 2024 Jul 30.
3

本文引用的文献

1
Validation of five hepatic steatosis algorithms in metabolic-associated fatty liver disease: A population based study.基于人群的研究验证五种肝脂肪变性算法在代谢相关脂肪性肝病中的应用。
J Gastroenterol Hepatol. 2022 May;37(5):938-945. doi: 10.1111/jgh.15799. Epub 2022 Mar 16.
2
The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates.非侵入性评分系统在肝移植供体候选人肝脂肪变性预测中的应用
Transplant Proc. 2019 Sep;51(7):2383-2386. doi: 10.1016/j.transproceed.2019.01.177. Epub 2019 Aug 8.
3
The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis.
Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East Asian populations.
评估主要指标在东亚人群中非酒精性脂肪性肝病中的临床实用性。
Biomark Med. 2023 Apr;17(8):445-454. doi: 10.2217/bmm-2023-0172. Epub 2023 Jul 14.
脂肪变性对肝移植结局的影响:荟萃分析。
Biomed Res Int. 2019 May 14;2019:3962785. doi: 10.1155/2019/3962785. eCollection 2019.
4
The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011.脂肪肝指数:代谢综合征的一种简单且有用的预测指标——基于2010 - 2011年韩国国民健康与营养检查调查的分析
Diabetes Metab Syndr Obes. 2019 Jan 24;12:181-190. doi: 10.2147/DMSO.S189544. eCollection 2019.
5
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝脏疾病的无创评估。
Gastroenterology. 2019 Apr;156(5):1264-1281.e4. doi: 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18.
6
Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.脂肪肝指数和肝脂肪变性指数预测 1 型糖尿病患者的非酒精性脂肪肝。
J Gastroenterol Hepatol. 2018 Jan;33(1):270-276. doi: 10.1111/jgh.13814.
7
Evaluation of donor workups and exclusions in a single-center experience of living donor liver transplantation.单中心活体肝移植供体检查与排除标准的评估
Liver Transpl. 2017 May;23(5):614-624. doi: 10.1002/lt.24762.
8
External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.用于评估韩国患者晚期肝纤维化的非酒精性脂肪性肝病纤维化评分的外部验证
J Gastroenterol Hepatol. 2017 May;32(5):1094-1099. doi: 10.1111/jgh.13648.
9
Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation.使用Optifast进行治疗可减轻肝脂肪变性,并提高活体肝移植的候选率。
Liver Transpl. 2016 Sep;22(9):1295-300. doi: 10.1002/lt.24495.
10
Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging.MRI化学位移成像上活体供肝脂肪分布的异质性
Ann Surg Treat Res. 2015 Jul;89(1):37-42. doi: 10.4174/astr.2015.89.1.37. Epub 2015 Jun 11.